IP Library Granted Patent US 10,028,696
Granted Patent B2
US 10,028,696 · App. 15/488,395 · Granted Jul 24, 2018

Methods and systems for evaluating the integrity of a uterine cavity

Inventors: Akos Toth (Cupertino, CA); Robin Bek (Campbell, CA); Dominique Filloux (Redwood City, CA)
Assignee: Minerva Surgical, Inc.
A61B5/4325A61B5/4836A61B18/042A61B18/1485A61M13/003A61B2018/00214A61B2018/00559A61B2018/00577A61B2018/00821A61B2018/147A61B2505/05
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,028,696
App. No.
15/488,395
Granted
Jul 24, 2018
Kind
B2
Abstract

Methods, systems and devices for evaluating the integrity of a uterine cavity. A method comprises introducing transcervically a probe into a patient's uterine cavity, providing a flow of a fluid (e.g., CO 2 ) through the probe into the uterine cavity and monitoring the rate of the flow to characterize the uterine cavity as perforated or non-perforated based on a change in the flow rate.

Claims (13)

1. A system for characterizing a patient's uterus, said system comprising:

a probe;

means for introducing a flow of gas through the probe;

means for measuring an inflow rate of the flow of gas through the probe when positioned in the uterus;

means for comparing a measured peak flow with a measured subsequent flow rate through the probe to produce a comparison of the measured peak flow rate and the measured subsequent flow rate; and

means for determining whether the uterus cavity is perforated based at least in part on the comparison of the peak and subsequent flow rates.

2. A system as in claim 1 , wherein the probe is adapted for transcervical introduction to the uterus.

3. A system as in claim 1 , wherein the gas introducing means is adapted to deliver the gas at a pre-determined constant pressure.

4. A system as in claim 3 , wherein the gas introducing means is adapted to introduce the gas at a pressure in the range from 0.025 psi to 1 psi.

5. A system as in claim 3 , wherein the gas introducing means is adapted to deliver gas at a pre-determined initial flow rate.

6. A system as in claim 5 , wherein the initial flow rate is in the range from 0.05 slpm to 0.2 slpm.

7. A system as in claim 5 , wherein the determining means detects when the initial flow rate drops by at least 10%, 20%, 30%, 40%, or 50% of the initial flow rate.

8. A system as in claim 5 , wherein the determining means detects when the initial flow rate drops to a value in the range from 0.01 slpm to 0.1 slpm.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2026
From: MINERVA SURGICAL, INC.
To: AXORA MEDICAL, INC.
Reel/Frame 075561/0186 →
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: MINERVA SURGICAL, INC.
Reel/Frame 074721/0585 →
SECURITY INTEREST Recorded Jan 30, 2026
From: AXORA MEDICAL, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 074537/0617 →
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: MINERVA SURGICAL, INC.
Reel/Frame 057770/0451 →
SECURITY INTEREST Recorded Oct 8, 2021
From: MINERVA SURGICAL, INC.
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 057758/0137 →
SECURITY INTEREST Recorded Dec 31, 2019
From: MINERVA SURGICAL, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 051395/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2018
From: TOTH, AKOS; BEK, ROBIN; FILLOUX, DOMINIQUE
To: MINERVA SURGICAL, INC.
Reel/Frame 046207/0843 →
Continuity (3)
Division 13361089 · Jan 30, 2012
Provisional Application 61439788 · Feb 4, 2011
Related Publication 20170215788A1 · Aug 3, 2017
Cited By (1)
US 12,274,557